After reading this article, the participant should be able to:
- 1. Identify the recently developed antimicrobials relevant to neurosurgery.
- 2. Recall the pharmacology of recently developed antimicrobials for neurosurgeons.
- 3. Describe the clinical spectrum and indications of newer antimicrobials.
Dr. Patil is Senior Resident, Division of Neurosurgery, Dr. Zaas is Fellow, Division of Infectious Diseases, Dr. Sexton is Professor, Division of Infectious Diseases, and Dr. Friedman is G.L. Odom Professer, Division of Neurosurgery, Box 3807, Duke University Medical Center, Durham, NC 27710.
Dr. Patil, Dr. Zaas, and Dr. Friedman have disclosed that they have no significant relationships with or financial interests in any commercial organizations pertaining to this educational activity. Dr. Sexton has disclosed that he receives grant/research support from Aventis, Pharmacia, and Merck and is a consultant for Pfizer and Merck.
Editor: Ali F. Krisht, M.D.*
University of Arkansas for Medical Sciences
Production Assistant: Ronalda Williams
Ossama Al-Mefty, M.D.
Evandro De Oliveira, M.D.
Curtis A. Dickman, M.D.
Rudolph Fahlbusch, M.D.
John Fox, M.D.
Allan Friedman, M.D.
Douglas Kondziolka, M.D.
Mark Linskey, M.D.
Tom Origitano, M.D.
Glenn Pait, M.D.
Kalmon Post, M.D.
Chandra Sen, M.D.
Robert Solomon, M.D.
Martin Weiss, M.D.
Gazi Yaşargil, M.D.
* Dr. Krisht has disclosed that he has no significant relationships with or financial interests in any commercial organizations pertaining to this educational activity.